期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021; 11 ()
Postpartum depression (PPD) is a common and serious mental health problem that is associated with maternal suffering and numerous negative consequence......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021; 11 ()
Aims: The therapeutic use of psychedelics is regaining scientific momentum, but similarly psychoactive ethnobotanical substances have a long history o......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021; 11 ()
Background: Antipsychotic agents (APS) are widely used drugs to treat psychotic symptoms and can effectively reduce both positive and negative symptom......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020; 10 ()
Compared with other inhaled anaesthetics, sevoflurane has a faster onset and offset, causes less irritation to the mucous membranes, and has a better ......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020; 10 ()
Background: This study is the first to examine the association between plasma levels of brain-derived neurotrophic factor (BDNF) and the antisuicidal ......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020; 10 ()
Introduction: Major depressive disorder (MDD) is a common affective disorder. Currently established pharmacotherapies lack rapid clinical response, th......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022; 12 ()
Numerous case reports of acute pancreatitis (AP) induced by olanzapine have been published. Little is, however, known about the clinical features of o......
期刊： THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022; 12 ()
Neuroleptic malignant syndrome (NMS) is a rare illness that results from reactions to antipsychotics. However, the diagnosis of NMS is challenging due......
